Description

Release Date: 10/07/2009
Expiration Date: 10/07/2010

Evidence-based treatment guidelines have been developed by the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III to help practitioners set goals when managing high cholesterol. These guidelines are based on multiple epidemiologic studies and clinical trials that have demonstrated consistently the clinical benefits of lipid-lowering therapy and low-density lipoprotein (LDL) goal attainment. Current guidelines recommend treatment goals should attain LDL < 100 mg/dL, and even lower for higher risk patients. Despite the evidence and the national clinical guidelines, treatment rates remain low with many patients not achieving their LDL targets.

Learning Objectives

Based on current evidence, participants should be able to:

1.      Assess CVD risk using validated tools
·Identify patients with risk factors
·Diagnose patients with metabolic syndrome

2.      Assess current guidelines and supporting evidence for ascertaining treatment goals

3.      Improve management of hypercholesterolemia
·Select appropriate pharmacologic therapies from among the current lipid lowering drugs
·Evaluate the importance of laboratory abnormalities that commonly occur in patients on lipid medications and be able to assess the likelihood that they are causally connected to the lipid therapy as well as the need to change or discontinue such therapies because of the lab findings.

Faculty

Moderator: 
Adolph M Hutter Jr, MD, MACC, FAHA, FESC
Clinical Cardiologist
Massachusetts General Hospital
Professor of Medicine
Harvard Medical School

Faculty
Mason Freeman, MD
Massachusetts General Hospital

Andrew Selwyn, MD, FRCP, FACC
Brigham Women's Hospital
Professor of Medicine Harvard Medical School

Jerome D. Cohen, MD, FACC
Emeritus Professor of Internal Medicine, Division of Cardiology St. Louis University Health Sciences Center

General Information

Release Date: 10/07/2009
Expiration Date: 10/07/2010

Dr. Freeman receives honoraria from Reed Medical Education (a company working as a logistics collaborator for the MGH Psychiatry Academy). The education programs conducted by the MGH Psychiatry Academy were supported through Independent Medical Education (IME) grants from pharmaceutical companies co-supported programs along with participant tuition. Commercial entities supporting the MGH Psychiatry Academy in 2009 are listed on the Academy's website www.mghcme.org.

Dr. Selwyn receives honoraria from Reed Medical Education (a company working as a logistics collaborator for the MGH Psychiatry Academy). The education programs conducted by the MGH Psychiatry Academy were supported through Independent Medical Education (IME) grants from pharmaceutical companies co-supported programs along with participant tuition. Commercial entities supporting the MGH Psychiatry Academy in 2009 are listed on the Academy's website www.mghcme.org.

Dr. Cohen is a consultant for Merck. He  receives honoraria from Reed Medical Education (a company working as a logistics collaborator for the MGH Psychiatry Academy). The education programs conducted by the MGH Psychiatry Academy were supported through Independent Medical Education (IME) grants from pharmaceutical companies co-supported programs along with participant tuition. Commercial entities supporting the MGH Psychiatry Academy in 2009 are listed on the Academy's website www.mghcme.org.

Dr. Hutter receives honoraria from Reed Medical Education (a company working as a logistics collaborator for the MGH Psychiatry Academy). The education programs conducted by the MGH Psychiatry Academy were supported through Independent Medical Education (IME) grants from pharmaceutical companies co-supported programs along with participant tuition. Commercial entities supporting the MGH Psychiatry Academy in 2009 are listed on the Academy's website www.mghcme.org.

Accreditation

Release Date: 10/07/2009
Expiration Date: 10/07/2010

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship and St. Luke’s and Roosevelt Hospitals and Reed Medical Education. Beth Israel Medical Center & St. Luke’s and Roosevelt Hospitals are accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION
Beth Israel Medical Center designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

POLICY ON FACULTY AND PROVIDER DISCLOSURE
It is the policy of Beth Israel Medical Center and St. Luke's and Roosevelt Hospitals that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Beth Israel Medical Center and St. Luke's and Roosevelt Hospitals have established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

Resolution of Conflict of Interest (COI)
It is the policy of Beth Israel Medical Center and St. Luke's and Roosevelt Hospitals has implemented a process to resolve COI for each CME activity. In order to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public,  MGH has resolved the conflict by Peer Review.

Supporters

Our evidence-based curriculum is supported by educational grants from:

• 
  
•